Advertise here
Advertise here
Headlines

Anton Buter | The BMJ

Anton Buter, a surgeon from South Africa, moved to Glasgow in 1998 to continue his training in upper gastrointestinal surgery. He was known for his modesty and private nature. He worked as a consultant at the Vale of Leven Hospital and helped reorganize services at the Royal Alexandra Hospital in 2003. He also contributed to…

Read More

Glasses Provide Audible Prompts for Blind Wearers

Researchers at the University of Technology Sydney have developed smart glasses for blind and low-vision users that use a combination of computer vision and sound to help users identify objects in their surroundings. The glasses produce “sound icons” based on the objects in the user’s field of view and have been shown to help users…

Read More

‘White Lung’ Pneumonia – What You Need to Know

Experts are discussing “white lung syndrome” pneumonia in children and its connection to outbreaks in Ohio, Massachusetts, and Europe. The condition is not officially recognized but refers to pneumonia detected as white areas on a lung X-ray. Symptoms include upper respiratory symptoms, difficulty breathing, and dehydration. There is no connection to COVID-19, but it is…

Read More

This Test May Guide AML Therapy for Black Pediatric Patients

A new study presented at the American Society of Hematology (ASH) annual meeting examines the implications of a polygenic score called ACS10 for Black pediatric patients with acute myeloid leukemia (AML). This score can predict patients’ response to cytarabine based on their genetic makeup and may help personalize treatment for Black pediatric patients with AML,…

Read More

Finerenone arrests CKD progression by effecting early reduction of albuminuria in diabetes patients

A post-hoc mediation analysis of FIGARO-DKD and FIDELIO-DKD trials showed that early albuminuria reduction with finerenne accounted for the majority of the treatment effect against chronic kidney disease progression in type 2 diabetes patients. The reduction in urine albumin-to-creatinine ratio mediated 84% of the treatment effect on kidney outcomes and 37% of the effect on…

Read More

How IT Became So Integral in Healthcare in So Little Time

Healthcare IT services have evolved to go beyond tech support, with companies offering a wider scope of services and greater expertise. The need for advanced IT support has increased due to the rising number of healthcare data breaches, ransomware attacks, and the growth of telehealth and administrative functions. IT partners now offer prevention-focused cybersecurity consulting,…

Read More

New material speeds up bone healing

Irish-based scientists have developed a new surgical implant that could transform the treatment of complex bone infections. The material, similar to human bone, contains tiny copper nanoparticles to kill bacteria and a genetic molecule to stimulate bone growth. Preclinical lab tests showed that the implants could stimulate bone regrowth in two weeks and stop 80%…

Read More

NIH Scientists discover biological basis for ME/CFS symptoms

A new study in Proceedings of the National Academy of Science discusses the role of the protein WASF3 in preventing ME/CFS patients from generating normal amounts of cellular energy. ME/CFS is a condition characterized by extreme fatigue and neurological concerns with no known cause. Research has shown that people with ME/CFS have high WASF3 levels…

Read More

Studies ‘urgently needed’ to understand social factors in blood cancer disparities

Research on social determinants of health for children and young adults with leukemia and lymphoma is necessary to improve care, as these factors impact outcome disparities for patients with hematological malignancies. Access to novel therapies, such as immunotherapies, targeted treatments, and diagnostics, is a significant issue, and disparities are driven by systemic racism and historic…

Read More

GLP-1 receptor agonists: European drug regulator asks makers for evidence of self-harm

The European Medicines Agency (EMA) is conducting a review of GLP-1 receptor agonists, including Ozempic, Saxenda, and Wegovy, used to treat type 2 diabetes and weight management, after reports of suicidal ideation and self-harm. The review was prompted by the Icelandic Medicines Agency following reports of these issues in people using liraglutide and semaglutide. The…

Read More

Phone Attachment for Pupil Measurements with Any Skin Tone

Researchers at the University of California San Diego have developed a smartphone attachment to measure changes in pupil size, useful for neurological conditions. This helps people with darker skin tones, who were previously underserved by available technology. The attachment fits over a smartphone camera and uses far-red light to capture images of the iris and…

Read More

Wasabi shows memory-boosting powers in study

A Japanese study found that wasabi, specifically its active ingredient 6-MSITC, may help boost memory in healthy adults aged 60 and older. The study, published in the journal Nutrients, involved 72 volunteers who showed an improvement in short- and long-term memory after taking a 100 mg wasabi extract supplement for three months. The researchers found…

Read More

EULAR publishes updated recommendations for SLE management

The European Alliance of Associations for Rheumatology (EULAR) has updated its recommendations for the management of systemic lupus erythematosus (SLE), a disease with diverse symptoms and traditionally limited treatment options. The updated recommendations, published in the Annals of the Rheumatic Diseases, emphasize multidisciplinary and individualized management, regular assessment of disease activity and organ damage, and…

Read More

Do You Have the Flu, RSV, COVID, or the Common Cold?

As winter approaches, there is concern about distinguishing between a common cold and the more serious RSV, COVID-19, and influenza. Symptoms such as runny noses, coughing, and congestion are common to all four illnesses, but differentiating the three viruses from a common cold is important. With similar symptoms, it is crucial to consider testing for…

Read More

In Real World, Patients With Myeloma Have Worse Outcomes

A study found that patients with multiple myeloma had dramatically worse outcomes in real-world settings than in clinical trials. Patients in the real-world experienced worse progression-free and overall survival on six of seven standard treatments compared with those in clinical trials. The analysis included nearly 4000 patients with multiple myeloma and compared real-world outcomes with…

Read More

Nursing bill passed in Parliament. What all you should know

The Parliament has passed the National Nursing and Midwifery Commission (NNMC) Bill, 2023, which aims to transform the nursing education and practice landscape. The Act will replace the Indian Nursing Council with a modern regulatory structure, elevating standards and enhancing professional conduct. The key provisions include the establishment of National and State Commissions, fixed tenures…

Read More

New MS Treatment Shows Promise in Trial

An experimental antibody therapy called ublituximab has been found to reduce symptom flare-ups in multiple sclerosis (MS) patients by preventing relapses and areas of inflammatory damage in the brain. If approved by the FDA, it would be the latest in a group of MS therapies called anti-CD20 monoclonal antibodies. Recent developments in this field show…

Read More

Health Bulletin 09/December/2023

NMC relief for overseas medical students in the Philippines allows students enrolled in BS courses before new regulations to continue their medical education. In Bihar, four doctors and a clerk at a medical institute have been accused of demanding sexual favors from paramedic students in exchange for better grades. Elsewhere, a doctor in Kerala has…

Read More

FDA Approves Not One, But Two Sickle Cell Disease Gene Therapies

The FDA approved gene therapies from Vertex Pharmaceuticals and Bluebird Bio for sickle cell disease. Both treatments, Casgevy and Lyfgenia, use gene therapy to potentially cure the inherited blood disorder and target those aged 12 and older. Sickle Cell Disease is a rare, debilitating, and life-threatening blood disorder with significant unmet need. Healthy red blood…

Read More

Don’t wait for the draft – Volunteer!

The author reflects on the power of volunteering and the impact it has on individuals and communities. They share their experiences of witnessing volunteering in the US and in Ireland, highlighting the diversity of volunteer work and the positive effects it has on society. They also speak about their own involvement as a volunteer for…

Read More

What is Urinary Incontinence? | Medical News Bulletin

Urinary incontinence is a common problem affecting approximately 30% of the world’s population. This includes stress incontinence, urge incontinence, overflow incontinence, total incontinence, and nocturnal enuresis. Causes for this include pelvic floor damage, neuromuscular damage, blockage of the urethra, and inability to control bladder movement. In addition, issues with your sleeping patterns and sex life…

Read More

Mosie Baby receives first 510(k) clearance for at-home artificial insemination kit

The at-home fertility care company Mosie Baby received FDA 510(k) clearance for its over-the-counter intravaginal insemination kit, allowing individuals to perform at-home insemination with fresh or frozen donor semen. The kit retails for $129.99 and includes two syringes and collection cups. Mosie’s CEO, Maureen Brown, expressed pride in helping over 100,000 families. The company plans…

Read More

Managing myopia progression results in long-term savings

Serge Resnikoff, MD, PhD, chair of the International Myopia Institute, discussed the cost of early management of myopia progression at the FLORetina meeting. He dispelled misconceptions about the high cost, stating that a recent study showed the lifetime cost of myopia management is equivalent to traditional myopia correction with single vision glasses. While special glasses,…

Read More

New Zealand reverses landmark tobacco controls

The new government of New Zealand (Aotearoa) plans to abandon tobacco control measures, prompting condemnation from the Māori health organization Hāpai Te Hauora. These measures include raising the legal age of sale for tobacco products, reducing retail outlets, and removing nicotine from tobacco products, aimed at creating a smoke-free generation. Smoking is a major cause…

Read More

Stretchable E-Skin for Robotic Prostheses

Researchers at the University of British Columbia have developed a highly sensitive e-skin for robotic prostheses in collaboration with the automotive company Honda. This technology allows robotic hands to perform delicate tasks such as grasping an egg or lifting a glass of water without breaking it. The skin is also capable of distinguishing between normal…

Read More

£1.9 million funding supports research on drivers of health disparities and infection risk across England

Dr Rosalind Eggo, an Associate Professor at LSHTM, has been awarded over £1.9 million in funding to research health disparities and associated infectious disease burden across England. Health disparities are preventable differences in health outcomes based on factors like income, ethnicity, education, age, gender, or disability. The research will analyze health records for over 20…

Read More

Are No-Spray Christmas Trees Better for You? What to Know

The article discusses the benefits and popularity of no-spray, pesticide-free Christmas trees among environmentally concerned customers. It highlights the success of Reed Island Christmas Tree Farm in southern Virginia, which offers eco-friendly trees that attract hundreds of customers. The article also emphasizes that the practice of organic tree farming, such as at Reed Island, is…

Read More

FDA OKs Two Gene-Editing Therapies for Sickle Cell Disease

The FDA approved two gene-editing treatments for patients aged 12 years or older with severe sickle cell disease, marking the first cell-based gene therapies for the condition. Exa-cel uses CRISPR gene-editing technology and demonstrated success in a clinical trial, while Lovo-cel uses a different technology and also showed positive results. Both treatments were found to…

Read More

Flaxseeds For Breast Cancer? Study Says Manipulating Gut Microbiota Using Them Could Reduce Risk

Researchers conducted a study on the manipulation of gut microbiota using flaxseeds and found that it could be beneficial in the prevention of breast cancer. Flaxseed is known for various health benefits, including relieving constipation, controlling cholesterol levels, and reducing inflammation. The study revealed that flaxseeds contain phytoestrogens called lignans that could influence the relationship…

Read More
Advertise here
error: Content is protected !!